Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: Effects on NAD metabolism and DNA repair

British Journal of Cancer

Volumn 76, Issue 7, 1997, Pages 845-851

  Boulton, S ^a   Kyle, S ^a   Durkacz, B W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

DNA repair; Nicotinamide adenine dinucleotide; Poly(ADP ribose) polymerase; Temozolomide; Tiazofurin

Indexed keywords

8 HYDROXY 2 METHYL 4(3H) QUINAZOLINONE; ALKYLATING AGENT; DNA; ENZYME INHIBITOR; METHYLNITRONITROSOGUANIDINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; QUINAZOLINONE DERIVATIVE; TEMOZOLOMIDE; TIAZOFURIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; GROWTH INHIBITION; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL;

EID: 0030752753     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.473     Document Type: Article

References (43)

1. Ahluwalia GS, Jayaram HN, Plowman JP, Cooney DA and Johns DG (1984) Studies on the mechanism of action of 2-β-D-ribofuranosylthiazole-4-carboxamide -V. Factors governing the response of murine tumours to tiazofurin. Biochem Pharmacol 33: 1195-1203
2. Althaus FR, Hofferer L, Kleczkowska HE, Malanga M, Naegeli H, Panzeter P and Realini C (1993) Histone shuttle driven by the automodification of poly(ADP-ribose) polymerase. Environ Mol Mutagen 22: 278-282
3. Balducci E, Emanuelli M, Magni G, Rafaelli N, Ruggieri S, Vita A and Natalini P (1992) Nuclear matrix associated NMN adenylyltransferase activity in human placenta. Biochem Biophys Res Commun 189: 1275-1279
4. Berger NA (1985) Symposium: cellular response to DNA damage: the role of poly(ADP-ribose). Radiat Res 101: 4-15
5. Bernofsky C and Swan M (1973) An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53: 452-458
6. Boulton S, Pemberton LC, Porteous JK, Curtin NJ, Griffin RJ, Golding, BT and Durkacz BW (1995) Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. Br J Cancer 72: 849-856
7. Bradford MM (1976) A rapid and sensitive method for the determination of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248-254
8. Branster MV and Morton RK (1956) Comparative rates of synthesis of diphosphopyridine nucleotide by normal and tumour tissue from mouse mammary gland: studies with isolated nuclei. Biochem J 63: 640-646
9. Cheng Y-C and Brockman WR (1983) Mechanisms of drug resistance and collateral sensitivities: bases for development of chemotherapeutic agents. In Development of Target-oriented Anticancer Drugs, Cheng Y-C, Goz B and Minkoff M (eds), pp. 107-117. Raven Press: New York
10. Cohen A and Barankiewicz J (1987) Metabolic consequences of DNA damage: alteration in purine metabolism following poly(ADP ribosyl)ation in human T-lymphoblasts. Arch Biochem Biophys 258: 498-503
11. Cooney DA, Jayaram HN, Gebeyehu G, Betts CR, Keeley JA, Marquez VE and Johns DG (1982) The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase inhibitory properties. Biochem Pharmacol 31: 2133-2136
12. de Murcia G and Ménissier-de Murcia JM (1994) Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 19: 172-176
13. n participates in DNA excision repair. Nature 283: 593-596
14. Emanuelli M, Natalini P, Raffaelli N, Ruggieri S, Vita A and Magni G (1992) NAD biosynthesis in human placenta: purification and characterisation of homogeneous NMN adenylyltransferase. Arch Biochem Biophys 296: 29-34
15. Fornace AJ Jr and Little JB (1977) DNA crosslinking induced by X-rays and chemical agents. Biochim Biophys Acta 477: 343-355
16. Fu CS, Swendseid ME, Jacob RA and McKee RW (1989) Biochemical markers for niacin status in young men: levels of erythrocyte niacin coenzymes and plasma tryptophan. J Nutr 119: 1949-1955
17. Glock GE and McLean P (1957) Levels of oxidised and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in tumours. Biochem J 65: 413-416
18. Griffin RJ, Pemberton LC, Rhodes D, Bleasdale C, Bowman K, Calvert AH, Curtin NJ, Durkacz BW, Newell DR, Porteous JK and Golding BT (1995) Novel potent inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). Anticancer Drug Design 10: 507-514
19. Grube K, Küpper JH and Bürkle A (1991) Direct stimulation of poly(ADP-ribose) polymerase in permeabilised cells by double-stranded DNA oligomers. Anal Biochem 193: 236-239
20. Halldorsson H, Gray DA and Shall S (1978) Poly(ADP-ribose) polymerase activity in nucleotide permeable cells. Febs Letts 85: 349-352
21. Heller B, Wang ZQ, Wagner EF, Radons J, Bürkle A, Fehsel K, Burkart V and Kolb H (1995) Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270: 11176-11180
22. Jacobson EJ, Nunbhakdi-Craig V, Smith DG, Chen HY, Wasson BL and Jacobson MK (1992) ADP-ribose polymer metabolism: implications for human nutrition. In ADP-Ribosylation Reactions, Poirier GG and Mureau P (eds), pp. 153-162. Springer: New York
23. Jayaram HN, Cooney DA, Glazer RI, Dion RL and Johns DG (1982) Mechanism of resistance to the oncolytic C-nucleoside, 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC286193). Biochem Pharmacol 31: 2557-2560
24. Jayaram HN, Zhen W and Gharebaghi K (1993) Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic cells. Cancer Res 53: 2344-2348
25. Jedeiken LA and Weinhouse S (1955) Metabolism of neoplastic tissue VI. Assay of oxidised and reduced diphosphopyridine nucleotide in normal and neoplastic tissues. J Biol Chem 213: 271-280
26. Kaufmann SH, Brunet G, Talbot B, Lamarr D, Dumas C, Shaper JH and Poirier G (1991) Association of poly(ADP-ribose) polymerase with the nuclear matrix: the role of intermolecular disulfide bond formation, RNA retention and cell type. Exp Cell Res 192: 524-535
27. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985
28. Kohn KW, Ewig RAG, Erickson LC and Zwelling LA (1981) Measurement of strand breaks and crosslinks by alkaline elution. In DNA Repair: A Laboratory Manual of Research Procedures, Friedberg EC and Hanawalt PC (eds), vol. 1, part B, pp. 379-401. Marcel Dekker: New York
29. Lautier D, Lagueux J, Thibodeau J, Ménard L and Poirier GG (1993) Molecular and biochemical features of poly(ADP-ribose) metabolism. Mol Cell Biochem 122: 171-193
30. Lindahl T, Satoh MS, Poirier GG and Klungland A (1995) Post- translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20: 405-411
31. Molinette M, Vermeulen W, Bürkle A, Ménissier-de Murcia J, Küpper JH, Hoeijmakers JH and De Murcia G (1993) Overproduction of the poly(ADP-ribose) polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in mammalian cells. EMBO J 12: 2109-2117
32. Newlands ES, Blackledge GRP, Slack JA, Rustin GJS, Smith DB, Stuart NSA, Quarterman CP, Hoffman R, Stevens MFG, Brampton MH and Gibson AC (1992 (Phase I trial of temozolomide (CCRG 81045: M & B 39831: NSC 362856). Br J Cancer 65: 287-291
33. Purnell MR and Whish WJD (1980) Novel inhibitors of poly(ADP-ribose synthase. Anal Biochem 27: 212-217
34. Radons J, Heller B, Bürkle A, Hartmann B, Rodriguez ML, Kroncke KD, Burkhart V and Kolb H (1994) Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD depletion. Biochem Biophys Res Commun 199: 1270-1277
35. Rechsteiner M, Hillyard D and Olivera BM (1976) Magnitude and significance of NAD turnover in human cell line D98/AH2. Nature 259: 695-696
36. Stevens MFG, Hickman JA, Langdon SP, Chubb D, Vickers L, Stone R, Baig G, Goddard C, Gibson NW, Slack JA, Newton C, Lunt E, Fizames C and Lavelle F (1987) Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG81045: M & B 39831), a novel drug with potential as an alternative to decarbazine. Cancer Res 47: 5846-5852
37. Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM and Sebolt-Leopold JS (1991) Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Design 7: 101-107
38. Ueda K, Kawaichi M and Hayaishi O (1982) Poly(ADP-ribose) synthetase. In ADP-Ribosylation Reactions, Hayaishi O and Ueda K (eds), pp. 117-155. Academic Press: NY
39. Wang Z-Q, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M and Wagner EI (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9: 509-520
40. Wilson DF, Erecinska M, Brown C and Silver IA (1977) Effect of of oxygen tension on cellular energetics. Am J Physiol 233: C135-C140
41. Wright SC, Wei QS, Kinder DH and Larrick JW (1996) Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumour necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease and DNA fragmentation. J Exp Med 183: 463-471
42. Yoon YS, Kim JW, Kang KW, Kim YS, Choi KH and Joe CO (1996) Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J Biol Chem 271: 9129-9134
43. Zhang J, Dawson VL, Dawson TM and Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689